Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Clinical trial NCT04287868 · COMPLETED

Trial details

NCT number: NCT04287868
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cervical Cancer HPV Cancers Anal Cancer Oropharyngeal Cancer Vulvar, Vaginal, Penile, Rectal Cancer

Start date: 2020-06-09
Primary completion: 2022-07-26
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.